Literature DB >> 15901904

BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.

A Keat1, N Barkham, A Bhalla, K Gaffney, H Marzo-Ortega, S Paul, F Rogers, M Somerville, R Sturrock, P Wordsworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15901904     DOI： 10.1093/rheumatology/keh669

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  23 in total

1.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

Review 2.  Diagnosis and management of ankylosing spondylitis.

Authors:  Claire M McVeigh; Andrew P Cairns
Journal:  BMJ       Date:  2006-09-16

3.  Ankylosing spondylitis in Ireland: patient access and response to TNF-α blockers.

Authors:  Aamir Saeed; Mumtaz Khan; Musaab Elmamoun; Mary Brady; Siobhan Morrissey; Alexander Duncan Fraser
Journal:  Rheumatol Int       Date:  2011-02-01       Impact factor: 2.631

Review 4.  A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.

Authors:  L Goh; A Samanta
Journal:  Rheumatol Int       Date:  2009-06-28       Impact factor: 2.631

5.  Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Authors:  Boksoon Chang; Hye Yun Park; Kyeongman Jeon; Joong Kyong Ahn; Hoon-Suk Cha; Eun-Mi Koh; Eun-Suk Kang; Won-Jung Koh
Journal:  Clin Rheumatol       Date:  2011-05-10       Impact factor: 2.980

6.  The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008.

Authors:  Alena Petříková; Tomáš Doležal; Jiří Klimeš; Milan Vocelka; Liliana Sedová; Jozef Kolář
Journal:  Rheumatol Int       Date:  2013-01-13       Impact factor: 2.631

Review 7.  Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.

Authors:  John Oldroyd; Lionel Schachna; Rachelle Buchbinder; Margaret Staples; Bridie Murphy; Molly Bond; Andrew Briggs; Marissa Lassere; Lyn March
Journal:  Int J Rheumatol       Date:  2009-08-02

9.  Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

Authors:  Paul A C Lord; Tracey M Farragher; Mark Lunt; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Rheumatology (Oxford)       Date:  2009-12-23       Impact factor: 7.580

10.  Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Authors:  Jong Wook Yun; Seong Yong Lim; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Hoon-Suk Cha; Eun-Mi Koh; Won-Jung Koh
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.